Document is current

Any future updates will be listed below

Do Orally Administered Immunoglobulin-Based Agents Represent the Future of IBD Therapeutics?

Crossref DOI link: https://doi.org/10.1007/S10620-015-3802-X

Published: 2015-11

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark